SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-005894
Filing Date
2024-02-28
Accepted
2024-02-28 16:01:07
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K sava20231231_10k.htm   iXBRL 10-K 1784968
2 EXHIBIT 4.2 ex_630601.htm EX-4.2 45269
3 EXHIBIT 21.1 ex_573342.htm EX-21.1 3583
4 EXHIBIT 23.1 ex_573343.htm EX-23.1 6346
5 EXHIBIT 31.1 ex_573344.htm EX-31.1 12559
6 EXHIBIT 31.2 ex_573345.htm EX-31.2 12423
7 EXHIBIT 32.1 ex_573346.htm EX-32.1 5126
8 EXHIBIT 97 ex_611641.htm EX-97 22700
14 alz.jpg GRAPHIC 71417
15 cab1ac4300e0img001.jpg GRAPHIC 28347
16 chgbsl.jpg GRAPHIC 22446
17 deccog.jpg GRAPHIC 49207
18 ex_611641img001.jpg GRAPHIC 11568
19 pg01.jpg GRAPHIC 38903
20 pic1.jpg GRAPHIC 34775
21 pic2.jpg GRAPHIC 39508
22 slide02.jpg GRAPHIC 22438
23 slide03.jpg GRAPHIC 28152
24 slide04.jpg GRAPHIC 26251
25 slide05.jpg GRAPHIC 45320
  Complete submission text file 0001437749-24-005894.txt   7487557

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA sava-20231231.xsd EX-101.SCH 53114
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sava-20231231_cal.xml EX-101.CAL 39872
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sava-20231231_def.xml EX-101.DEF 354603
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sava-20231231_lab.xml EX-101.LAB 324511
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sava-20231231_pre.xml EX-101.PRE 386153
89 EXTRACTED XBRL INSTANCE DOCUMENT sava20231231_10k_htm.xml XML 773510
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41905 | Film No.: 24695034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)